Yi-Bin Chen

67PUBLICATIONS
314CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Criminological theoriesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|May 26, 2026
The 2026 definition of ruxolitinib refractoriness in severe acute GVHD.

|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Apr 24, 2026
Donor Selection in the Post-Transplant Cyclophosphamide Era: Do the Little Things Matter?

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

Pageof 12

Frequent Collaborators

33 joint publications

Zachariah DeFilipp

11 joint publications

John E Levine

10 joint publications

Elizabeth O Hexner

9 joint publications

Mark J Levis